Nontuberculous Mycobacterial Lung Disease (NTM-LD): Overcoming Common Pitfalls in Diagnosis and Treatment

FACULTY

Charles L. Daley, MD
Chief, Division of Mycobacterial and Respiratory Infections
Professor of Medicine
National Jewish Health
Denver, Colorado

Shannon H. Kasperbauer, MD
Associate Professor of Medicine
Department of Medicine
Division of Mycobacterial and Respiratory Infections
National Jewish Health
Denver, Colorado

PROGRAM OVERVIEW

This enduring activity will explore the diagnosis and management of NTM-LD. Whiteboard animations will identify common pitfalls that lead to delays in diagnosis and look at the mechanism of action of novel therapies for refractory disease. A case-based didactic lecture led by expert faculty will review guideline-recommended care, strategies to minimize adverse events, and clinical trial data on newer treatment options.

TARGET AUDIENCE

This activity is designed to meet the educational needs of pulmonology professionals (including MDs, DOs, NPs, PAs and pharmacists) who have a role in the diagnosis and treatment of patients with NTM-LD.

LEARNING OBJECTIVES

After completing this activity, learners should be better able to:

• Reduce time to diagnosis in patients with suspected NTM-LD
• Individualize treatment selection for patients with NTM-LD in frontline and refractory settings based on clinical guidelines and patient characteristics
• Evaluate the role of amikacin liposome inhalation suspension (ALIS) in the treatment of patients with NTM-LD
• Optimize strategies to avoid and manage the adverse effects of antibiotic therapy in patients with NTM-LD and facilitate the completion of therapy

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in this enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in caring for patients with NTM-LD.
CNE Credits: 1.0 ANCC Contact Hour.

CNE ACCREDITATION STATEMENT

Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Charles Daley, MD reports the following financial relationships with relevant companies within the past 24 months:

Relationship	Manufacturer
Consultant/Advisor	AN2, Genentech, Insmed, Pfizer
Advisory Board	AstraZeneca, AN2, Insmed, Matinas, Paratek, Spero Therapeutics
Industry/Investigator Initiated Research	Beyond Air, BugWorks, Insmed, Paratek, AN2
Data Monitoring Committee	Lilly, Otsuka

Shannon Kasperbauer, MD is a speaker for AN2 Pharmaceuticals, Insmed and Paratek, and serves as a consultant for AN2 Pharmaceuticals, Insmed and Paratek.

CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review

The content of this activity was peer reviewed by a nurse reviewer.

Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner

The reviewer of this activity has nothing to disclose.

Staff Planners and Managers

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

• Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
• Diana Tommasi, PharmD, Medical Director for Med Learning Group, has nothing to disclose.
• Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.
• Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
• Russie Allen, Accreditation and Outcomes Manager for Med Learning Group, has nothing to disclose.
• Felecia Beachum, Program Manager for Med Learning Group, has nothing to disclose.
• Naomi De Brito, Program Coordinator for Med Learning Group has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and nonapproved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:

1. Read the CME/CNE information and faculty disclosures.
2. Participate in the enduring activity.
3. Complete the online post-test and evaluation.

You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making skills before applying any information, whether provided here or by others, for any professional use.

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

For CME questions, please contact Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

 

Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.